These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18812618)

  • 1. Management of patients with ICDs at the end of life (EOL): a qualitative study.
    Kelley AS; Mehta SS; Reid MC
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician attitudes toward end-stage heart failure: a national survey.
    Hauptman PJ; Swindle J; Hussain Z; Biener L; Burroughs TE
    Am J Med; 2008 Feb; 121(2):127-35. PubMed ID: 18261501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinician Attitudes Regarding ICD Deactivation in DNR/DNI Patients.
    Bradley A; Marks A
    J Hosp Med; 2017 Jul; 12(7):498-502. PubMed ID: 28699936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EfCCNa survey: European intensive care nurses' attitudes and beliefs towards end-of-life care.
    Latour JM; Fulbrook P; Albarran JW
    Nurs Crit Care; 2009; 14(3):110-21. PubMed ID: 19366408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.
    Goldstein NE; Mehta D; Teitelbaum E; Bradley EH; Morrison RS
    J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):2-6. PubMed ID: 18095036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
    Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
    Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' knowledge of implantable defibrillator treatment: are we good enough?
    Kinch Westerdahl A; Frykman V
    Europace; 2017 Jul; 19(7):1163-1169. PubMed ID: 28201494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
    Fluur C; Bolse K; Strömberg A; Thylén I
    J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.